Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02019498
Other study ID # RelaxLWS-13
Secondary ID
Status Terminated
Phase N/A
First received December 18, 2013
Last updated August 2, 2016
Start date April 2014
Est. completion date July 2016

Study information

Verified date February 2016
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of the pragmatic randomized study is to evaluate whether additional relaxation technique is more effective in the reduction of chronic low back pain compared to usual care alone.


Description:

Objective: To evaluate whether additional relaxation technique is more effective in the reduction of chronic low back pain compared to usual care alone.

Study design: Open single-centered randomized two-armed pragmatic trial.

Participants: 220 patients aged 18-65 years with chronic (>12 weeks) low back pain and a mean pain score ≥ 4 on a Numeric Rating scale (NRS) in the last week before randomization who will be randomly allocated to two groups (relaxation, usual care alone as waiting list)

Intervention: Participants apply either a daily 15-minute relaxation exercise guided by a smartphone application ("app"). or apply no additional intervention. The exercise should be applied daily, (minimally five days per week) for 6 months. The app contains audios to guide autogenic training, muscle relaxation training and guided imagery. On a daily basis, participants can select one of the three exercises which they want to apply.

Main outcome measure: The primary outcome is the mean pain intensity after 3 months measured by the daily pain intensity on the NRS.


Recruitment information / eligibility

Status Terminated
Enrollment 50
Est. completion date July 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- female or male

- 18-65 years of age

- chronic low back pain for at least 12 weeks

- if additional back pain is reported, low back pain has to be predominant

- intensity of the average low back pain = 4 on the numeric rating scale (NRS) in the last week

- presence of a smartphone (iphone, Android phone) and willingness to do data entry through a smart phone application (App)

- willingness to be randomized, to apply study intervention according to the protocol, to complete the baseline questionnaire in paper form and electronic questionnaires and diaries provided by an App physical and mental ability to participate in the study

- written and oral informed consent

Exclusion Criteria:

- low back pain caused by a known malignant disease

- neck pain caused by trauma

- known rheumatic disorder

- history or planned surgery of the spinal column of the low back in the next 6 months

- known neurological symptoms e.g radicular symptoms because of prolapsed vertebral disc

- regular intake of analgesics (>1x per week) because of additional diseases

- intake of centrally acting analgesics

- known severe acute or chronic disorder, that do not allow participation in the therapy

- other known diseases, that do not allow participation in the therapy

- known alcohol or substance abuse

- no sufficient German language skills

- current application for a benefit

- participation in another clinical trial during six months before the study and parallel to the study

- conducting regular relaxation techniques, mindfulness training or meditation six weeks before the study or planned in the next 6 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
Relaxation exercise
Participants allocated to the relaxation group will apply daily but at least five days a week a 15-minutes relaxation exercise, guided by a smartphone application (App). On a daily basis, participants can select one out of the three exercises (guided imagery, mindfulness based training, autogenic training) which they want to apply
Other:
ususal care
Participants allocated to the usual care waiting list group will continue with their usual care without receiving any additional therapy

Locations

Country Name City State
Germany Charité Universitätsmedizin Berlin Berlin, Germany Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome is the mean pain intensity over 3 months measured by the daily pain intensity on the Numeric rating scale (NRS) 3 months No
Secondary Mean pain intensity measured by the daily pain intensity on the NRS 6 months No
Secondary Mean pain intensity measured weekly as the average pain intensity of the last seven days on a NRS 3 and 6 months No
Secondary Pain acceptance German version of Chronic Pain Acceptance Questionnaire 3 and 6 months No
Secondary Stress NRS 3 and 6 months No
Secondary Suspected adverse reaction 3 and 6 months Yes
Secondary Number of Serious adverse event 3 and 6 months Yes
Secondary medication intake 3 and 6 months No
Secondary Number of sick leave days 3 and 6 months No
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3